Deal Flow Alert ⚡ Corstasis VP Hire
Corstasis just named a VP of Medical Affairs. Next touch: clinical trial management pitch to speed pipeline and hit quota.
Published on
Do not index
Do not index
🚀 Battle Card: Corstasis Therapeutics Inc.
Quick trigger:
👤 Decision Maker in the News
- Amin M. Medjamia M.D., Vice President of Medical Affairs · 🔗 LinkedIn
💡 Why It Matters
- Seasoned clinical affairs leader joins as company advances Enbumyst™ toward pivotal PDUFA date → Source
- Timing your pitch to this Corstasis Therapeutics Inc. sales trigger ensures alignment with their clinical roadmap
🎯 Core Pain Point
- High regulatory scrutiny for novel outpatient nasal therapies
- Urgent need to scale evidence generation for FDA submission
💰 What to Pitch
- Primary: Clinical trial management platform → Streamlined evidence generation & regulatory compliance
- Expansion: Medical communications service → Enhanced stakeholder engagement & clinical algorithm support
🗺️ Quick Context
- HQ: Henderson, NV
- Employees: ≈ 100
- Rev: ≈ $20 M
- Website: https://www.corstasis.com
This Corstasis Therapeutics Inc. sales trigger is a green light to move on clinical strategy conversations.
🤼 Competitive Intel
Which other vendors you’ll probably face to win Corstasis Therapeutics Inc.’s business.
- Veeva Systems — Clinical Data Management / CTMS
- Unique edge: Unified clinical, regulatory & medical platform
- Selected by VP Medical Affairs for data integration
- Medidata (Dassault Systèmes) — Clinical Trial Management
- Unique edge: AI-driven trial optimization
- Evaluated by clinical ops for advanced analytics
- Parexel — Medical Affairs & Regulatory Consulting
- Unique edge: End-to-end evidence generation services
- Chosen by former VP Ops for FDA submission success
- ICON plc — Contract Research Organization
- Unique edge: Global trial execution & medical engagement
- Considered by Medical Affairs for scale & expertise
✅ Do-Now Checklist
Connect with decision maker on LinkedIn (link above)
Generate email + DM referencing the Corstasis Therapeutics Inc. sales trigger
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑❑
OFFER_BRIEF = ❑Clinical trial management platform❑
PROOF_METRIC = ❑25% faster trial startup❑
CTA_STYLE = ❑quick_call❑
TONE = ❑friendly❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Amin
COMPANY = Corstasis Therapeutics Inc.
DEPT = Medical Affairs
SIZE = ≈ TBD
BOTTLENECK = ≈ TBD
EVENT = Appointment of Dr. Amin Medjamia as VP of Medical Affairs
DETAIL = Appointment of Dr. Amin Medjamia as VP of Medical Affairs
PAIN = High regulatory scrutiny for novel outpatient nasal therapies
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250911973833&div=41152219
SIM_CO = ≈ TBD
WIN_METRIC = ≈ TBD
NEXT_SIZE = ≈ TBD
EMP_EST = ≈ 100
REV_EST = ≈ $20M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: ≈ TBD-person Medical Affairs
Amin—noticed your Medical Affairs team is ≈ TBD.
That’s when ≈ TBD slows growth.
We helped ≈ TBD fix this with Clinical trial management platform.
Result: ≈ TBD.
Quick call?
PS—next bottleneck hits ≈ TBD.
DM ≤45 words, TONE:
Saw your post about Appointment of Dr. Amin Medjamia as VP of Medical Affairs — High regulatory scrutiny for novel outpatient nasal therapies.
Clinical trial management platform. 25% faster trial startup.
Quick chat?